PaulF.SchellhammerMD
Urology • Virginia Beach, VAProfessor at Eastern Virginia Medical School. He is past chairman of the Department of Urology and program director of the Resident Training Program at EVMS.
Dr. Schellhammer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 Clearfield Ave
Virginia Beach, VA 23462Phone+1 757-442-6050Fax+1 757-961-3696
Education & Training
Virginia Commonwealth University Health SystemResidency, Urology, 1972 - 1973
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 1966 - 1968
Weill Cornell MedicineClass of 1966
Certifications & Licensure
VA State Medical License 1974 - 2026
NC State Medical License 2020 - 2022
OH State Medical License 1967 - 1974- American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy Start of enrollment: 2003 Jul 01
- Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) Start of enrollment: 2004 Apr 01
Publications & Presentations
PubMed
- 59 citationsRole of Estrogen in Normal Male Function: Clinical Implications for Patients With Prostate Cancer on Androgen Deprivation TherapyErik Wibowo, Paul F. Schellhammer, Richard J. Wassersug
The Journal of Urology. 2011-01-01 - 96 citationsAndrogen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with AntiandrogensE. David Crawford, Paul F. Schellhammer, David G. McLeod, Judd W. Moul, Celestia S. Higano
The Journal of Urology. 2018-05-03 - 79 citationsSurvival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry.Oliver Sartor, Andrew J. Armstrong, Chiledum Ahaghotu, David G. McLeod, Matthew R. Cooperberg
Prostate Cancer and Prostatic Diseases. 2020-02-28
Press Mentions
“Prostate Cancer Today” — Dr. Franz DeBruyne Joins Meeting FacultySeptember 12th, 2018- Second CureTalk Discussion on Living Well with Prostate CancerMay 30th, 2017
- Listen to Dr. Schellhammer Discussing “Living Well with Prostate Cancer”April 25th, 2017
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
